
Beauty Health (SKIN) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
78.2M
Gross Profit
49.1M
62.81%
Operating Income
-2.7M
-3.45%
Net Income
19.7M
25.21%
EPS (Diluted)
$0.03
Balance Sheet Metrics
Total Assets
673.8M
Total Liabilities
627.8M
Shareholders Equity
46.1M
Debt to Equity
13.63
Cash Flow Metrics
Operating Cash Flow
-577.0K
Free Cash Flow
1.9M
Revenue & Profitability Trend
Beauty Health Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 334.3M | 398.0M | 365.9M | 260.1M | 119.1M |
Cost of Goods Sold | 152.0M | 242.9M | 117.1M | 81.5M | 51.9M |
Gross Profit | 182.3M | 155.1M | 248.8M | 178.5M | 67.2M |
Gross Margin % | 54.5% | 39.0% | 68.0% | 68.6% | 56.4% |
Operating Expenses | |||||
Research & Development | 6.3M | 10.1M | 8.4M | 8.2M | 3.4M |
Selling, General & Administrative | 243.8M | 275.9M | 266.2M | 210.3M | 81.0M |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 250.1M | 286.0M | 274.6M | 218.5M | 84.4M |
Operating Income | -67.8M | -130.9M | -25.8M | -39.9M | -17.2M |
Operating Margin % | -20.3% | -32.9% | -7.1% | -15.4% | -14.4% |
Non-Operating Items | |||||
Interest Income | 16.6M | 23.2M | 9.2M | 39.0K | 0 |
Interest Expense | 10.4M | 13.6M | 13.4M | 11.8M | 21.3M |
Other Non-Operating Income | 32.0M | 19.5M | 75.4M | -329.0M | -26.0K |
Pre-tax Income | -29.6M | -101.9M | 45.3M | -380.6M | -38.5M |
Income Tax | -452.0K | -1.8M | 1.1M | -1.9M | -9.3M |
Effective Tax Rate % | 0.0% | 0.0% | 2.5% | 0.0% | 0.0% |
Net Income | -29.1M | -100.1M | 44.2M | -378.8M | -29.2M |
Net Margin % | -8.7% | -25.2% | 12.1% | -145.6% | -24.5% |
Key Metrics | |||||
EBITDA | 16.1M | -67.9M | 4.6M | -26.4M | -2.7M |
EPS (Basic) | $-0.23 | $-0.76 | $0.30 | $-3.67 | $-0.23 |
EPS (Diluted) | $-0.36 | $-0.76 | $0.23 | $-3.67 | $-0.23 |
Basic Shares Outstanding | 123827372 | 131680605 | 147554090 | 102114883 | 125399913 |
Diluted Shares Outstanding | 123827372 | 131680605 | 147554090 | 102114883 | 125399913 |
Income Statement Trend
Beauty Health Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 370.1M | 523.0M | 568.2M | 901.9M | 9.5M |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 27.6M | 54.7M | 76.5M | 46.8M | 18.6M |
Inventory | 69.1M | 91.3M | 109.7M | 35.3M | 23.2M |
Other Current Assets | 9.5M | 28.9M | 27.6M | 12.3M | - |
Total Current Assets | 477.1M | 698.3M | 783.3M | 1.0B | 59.1M |
Non-Current Assets | |||||
Property, Plant & Equipment | 14.3M | 13.0M | 16.3M | 16.4M | 1.2M |
Goodwill | 294.5M | 313.8M | 295.6M | 303.4M | 248.0M |
Intangible Assets | 47.5M | 62.1M | 46.4M | 56.0M | 50.9M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 18.0M | 16.6M | 15.0M | 7.0M | 5.1M |
Total Non-Current Assets | 208.6M | 230.9M | 219.8M | 217.9M | 163.7M |
Total Assets | 685.7M | 929.1M | 1.0B | 1.2B | 222.8M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 21.9M | 44.8M | 28.5M | 29.0M | 18.5M |
Short-term Debt | 5.1M | 4.6M | 5.0M | 3.7M | 512.0K |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | - |
Total Current Liabilities | 68.2M | 115.0M | 71.7M | 76.4M | 30.9M |
Non-Current Liabilities | |||||
Long-term Debt | 563.0M | 747.7M | 746.8M | 742.7M | 216.0M |
Deferred Tax Liabilities | 396.0K | 702.0K | 2.0M | 3.6M | 4.0M |
Other Non-Current Liabilities | 1.8M | 2.8M | 15.5M | 93.8M | 1.9M |
Total Non-Current Liabilities | 565.7M | 754.7M | 764.3M | 840.1M | 221.9M |
Total Liabilities | 633.9M | 869.7M | 836.0M | 916.5M | 252.8M |
Equity | |||||
Common Stock | 12.0K | 12.0K | 14.0K | 16.0K | 4.0K |
Retained Earnings | -508.0M | -478.9M | -378.8M | -418.7M | -43.6M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 51.8M | 59.4M | 167.1M | 302.3M | -30.0M |
Key Metrics | |||||
Total Debt | 568.2M | 752.3M | 751.8M | 746.4M | 216.5M |
Working Capital | 409.0M | 583.2M | 711.6M | 924.5M | 28.2M |
Balance Sheet Composition
Beauty Health Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -29.1M | -100.1M | 44.2M | -378.8M | -29.2M |
Depreciation & Amortization | 33.7M | 34.7M | 22.9M | 17.9M | 14.5M |
Stock-Based Compensation | 26.7M | 22.5M | 28.5M | 12.4M | 363.0K |
Working Capital Changes | 904.0K | -1.6M | -136.9M | -42.8M | 11.0K |
Operating Cash Flow | 14.3M | -34.3M | -28.5M | -338.1M | -11.4M |
Investing Activities | |||||
Capital Expenditures | -756.0K | -3.8M | -10.8M | -11.2M | - |
Acquisitions | - | 0 | 0 | -22.9M | 0 |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | -756.0K | -22.3M | -12.3M | -33.3M | 0 |
Financing Activities | |||||
Share Repurchases | 0 | -32.4M | -160.0M | 0 | -154.0K |
Dividends Paid | - | - | - | - | 0 |
Debt Issuance | - | 0 | 0 | 750.0M | 30.0M |
Debt Repayment | -156.1M | 0 | 0 | -230.5M | -16.8M |
Financing Cash Flow | -158.3M | -37.4M | -205.2M | 765.7M | 3.3M |
Free Cash Flow | 9.3M | 8.7M | -124.0M | -44.0M | -16.3M |
Net Change in Cash | -144.8M | -94.0M | -246.0M | 394.3M | -8.1M |
Cash Flow Trend
Beauty Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-8.72
Forward P/E
-12.88
Price to Book
3.53
Price to Sales
0.84
PEG Ratio
0.00
Profitability Ratios
Profit Margin
-6.13%
Operating Margin
-3.45%
Return on Equity
-26.55%
Return on Assets
-4.45%
Financial Health
Current Ratio
5.15
Debt to Equity
509.08
Beta
1.20
Per Share Data
EPS (TTM)
$-0.18
Book Value per Share
$0.58
Revenue per Share
$2.48
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
skin | 253.6M | -8.72 | 3.53 | -26.55% | -6.13% | 509.08 |
Procter & Gamble | 411.7B | 24.09 | 7.18 | 31.24% | 18.95% | 69.86 |
Colgate-Palmolive | 75.3B | 23.62 | 96.74 | 398.04% | 14.54% | 832.51 |
Edgewell Personal | 1.5B | 17.79 | 0.71 | 4.12% | 2.94% | 90.06 |
Spectrum Brands | 1.3B | 24.50 | 0.71 | 3.01% | 2.56% | 40.13 |
Yatsen Holding | 941.8M | -1.33 | 0.28 | -15.08% | -14.10% | 5.71 |
Financial data is updated regularly. All figures are in the company's reporting currency.